3 ms·
Paradoxically, the economic incentive is weak. The research is expensive and anything you discover will be very sparsely administered (as last resort, to slow d
by praptak 11y ago
Paradoxically, the economic incentive is weak. The research is expensive and anything you discover will be very sparsely administered (as last resort, to slow down resistance). For this reason recovering the cost might be problematic.
- giarc 11y agoEven if it was widely used, the other problem is that a patient takes it for 10-14 days and then stops. Drug companies like products that patients take 1 pill a day for the rest of their life.
- JeremyNT 11y agoThe way that our society funds pharmaceutical research (by granting subsidized, temporary monopolies on any resulting products) seems completely incapable of responding to this sort of situation. A radically different incentive structure seems necessary...
- api 11y agoYet another bit of reality that conflicts with market fundamentalism -- some things that are not profitable are still good and necessary.